Exact Mass: 345.1423

Exact Mass Matches: 345.1423

Found 74 metabolites which its exact mass value is equals to given mass value 345.1423, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

2-(Furan-2-yl)-7-phenethyl-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine

4-(furan-2-yl)-10-(2-phenylethyl)-3,5,6,8,10,11-hexaazatricyclo[7.3.0.0²,⁶]dodeca-1(9),2,4,7,11-pentaen-7-amine

C18H15N7O (345.1338)


D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D020011 - Protective Agents SCH 58261 is a potent, selective and competitive antagonist of adenosine A2A receptor with an IC50 of 15 nM, and displays 323-, 53- and 100-fold more selective for A2A receptor than A1, A2B, and A3 receptors, respectively[1][2][3].

   

Tetraisopropylpyrophosphoric acid amide

({[bis(propan-2-yl)amino](propan-2-yloxy)phosphoryl}oxy)(propan-2-yloxy)phosphinic acid

C12H29NO6P2 (345.147)


   

Leptoclinidamine A

Leptoclinidamine A

C16H19N5O4 (345.1437)


   

2-(n-butyl)-5-hydroxy-7-phenyl-2H-benzo[de]isoquinoline-1,6-dione

2-(n-butyl)-5-hydroxy-7-phenyl-2H-benzo[de]isoquinoline-1,6-dione

C22H19NO3 (345.1365)


   

19-O-Methylangustoline

(-)-O-Methylangustoline

C21H19N3O2 (345.1477)


   

Maybridge4_000489

Maybridge4_000489

C16H19N5O4 (345.1437)


   
   

Isatin biscresol

Isatin biscresol

C22H19NO3 (345.1365)


   

(2-benzamido-1-phenylethyl) benzoate

(2-benzamido-1-phenylethyl) benzoate

C22H19NO3 (345.1365)


   
   
   

2-Butyl-5-hydroxy-7-phenyl-6H-benzo[de]isoquinoline-1,6(2H)-dione

2-Butyl-5-hydroxy-7-phenyl-6H-benzo[de]isoquinoline-1,6(2H)-dione

C22H19NO3 (345.1365)


   
   

1-(1-Methoxyethyl)-8,13-dihydroindolo[2,3:3,4]pyrido[1,2-b][2,7]naphthyridine-5(7H)-one

1-(1-Methoxyethyl)-8,13-dihydroindolo[2,3:3,4]pyrido[1,2-b][2,7]naphthyridine-5(7H)-one

C21H19N3O2 (345.1477)


   

16-Methoxycarbonyl naufoline

16-Methoxycarbonyl naufoline

C21H19N3O2 (345.1477)


   

4,5-DIDEMETHYLSIMMONDSIN

4,5-DIDEMETHYLSIMMONDSIN

C15H23NO8 (345.1424)


   

3,3-Bis(3-methyl-4-hydroxyphenyl)indoline-2-on

2H-Indol-2-one, 1,3-dihydro-3,3-bis(4-hydroxy-3-methylphenyl)-

C22H19NO3 (345.1365)


   

2-[4-[1-(1,3-benzodioxol-5-yl)propan-2-yl]piperazin-1-yl]-4-methyl-1,3-thiazole

2-[4-[1-(1,3-benzodioxol-5-yl)propan-2-yl]piperazin-1-yl]-4-methyl-1,3-thiazole

C18H23N3O2S (345.1511)


   

6-Methylheptanoic acid - cobalt (2:1)

6-Methylheptanoic acid - cobalt (2:1)

C16H30CoO4 (345.1476)


   

Metofoline

Isoquinoline,1-[2-(4-chlorophenyl)ethyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-

C20H24ClNO2 (345.1495)


C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist

   

3-(3-(NAPHTHALEN-1-YLOXY)PROPYL)-1H-INDOLE-2-CARBOXYLIC ACID

3-(3-(NAPHTHALEN-1-YLOXY)PROPYL)-1H-INDOLE-2-CARBOXYLIC ACID

C22H19NO3 (345.1365)


   

Piperidine,2-[(4R)-2,2-diphenyl-1,3-dioxolan-4-yl]-, hydrochloride (1:1), (2R)-

Piperidine,2-[(4R)-2,2-diphenyl-1,3-dioxolan-4-yl]-, hydrochloride (1:1), (2R)-

C20H24ClNO2 (345.1495)


   

N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethoxy)phenyl)acetamide

N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethoxy)phenyl)acetamide

C15H19BF3NO4 (345.1359)


   

Savolitinib

Savolitinib

C17H15N9 (345.145)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor

   

1,1,2-trimethyl-3-(4-sulfobutyl)-1h-benz[e]indolium hydroxide, inner salt

1,1,2-trimethyl-3-(4-sulfobutyl)-1h-benz[e]indolium hydroxide, inner salt

C19H23NO3S (345.1399)


   

3-[1-[5-(Trifluoromethyl)-2-pyridinyl]-4-piperidinyl]-1H-indole

3-[1-[5-(Trifluoromethyl)-2-pyridinyl]-4-piperidinyl]-1H-indole

C19H18F3N3 (345.1453)


   

Piperidine,2-(2,2-diphenyl-1,3-dioxolan-4-yl)-, hydrochloride (1:1)

Piperidine,2-(2,2-diphenyl-1,3-dioxolan-4-yl)-, hydrochloride (1:1)

C20H24ClNO2 (345.1495)


   

2-Pyridinecarboxylic acid, 4-[4-(methylamino)-3-nitrophenoxy]-, 1,1-dimethylethyl ester

2-Pyridinecarboxylic acid, 4-[4-(methylamino)-3-nitrophenoxy]-, 1,1-dimethylethyl ester

C17H19N3O5 (345.1325)


   

t-butyl-4-n-z-amino-2-fluoro-benzoate

t-butyl-4-n-z-amino-2-fluoro-benzoate

C19H20FNO4 (345.1376)


   

2-(5-((TERT-BUTOXYCARBONYL)AMINO)-6-OXO-2-PHENYLPYRIMIDIN-1(6H)-YL)ACETIC ACID

2-(5-((TERT-BUTOXYCARBONYL)AMINO)-6-OXO-2-PHENYLPYRIMIDIN-1(6H)-YL)ACETIC ACID

C17H19N3O5 (345.1325)


   

N-methyl-2-(4-nitrophenoxy)-N-[2-(4-nitrophenyl)ethyl]ethanamine

N-methyl-2-(4-nitrophenoxy)-N-[2-(4-nitrophenyl)ethyl]ethanamine

C17H19N3O5 (345.1325)


   

Mal-PEG4-acid

Mal-PEG4-acid

C15H23NO8 (345.1424)


   

(4-PHENYLPIPERAZIN-1-YL)PIPERIDIN-4-YL-METHANONE DIHYDROCHLORIDE

(4-PHENYLPIPERAZIN-1-YL)PIPERIDIN-4-YL-METHANONE DIHYDROCHLORIDE

C16H25Cl2N3O (345.1375)


   

3-[5-tert-butyl-2-[(4-fluorophenyl)methyl]pyrazol-3-yl]-4-methyl-1H-1,2,4-triazole-5-thione

3-[5-tert-butyl-2-[(4-fluorophenyl)methyl]pyrazol-3-yl]-4-methyl-1H-1,2,4-triazole-5-thione

C17H20FN5S (345.1423)


   

Cobalt bis(2-ethylhexanoate)

Cobalt bis(2-ethylhexanoate)

C16H30CoO4 (345.1476)


   

(5,6-Diphenyl-furo[2,3-D]pyrimidin-4-ylamino)-acetic

(5,6-Diphenyl-furo[2,3-D]pyrimidin-4-ylamino)-acetic

C21H19N3O2 (345.1477)


   

1-Phenyl-2-propanamine-D-glucaric acid (1:1)

1-Phenyl-2-propanamine-D-glucaric acid (1:1)

C15H23NO8 (345.1424)


   

Gevotroline hydrochloride

Gevotroline hydrochloride

C19H21ClFN3 (345.1408)


C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

   

2-[[anilino(oxo)methyl]amino]-N-(phenylmethyl)benzamide

2-[[anilino(oxo)methyl]amino]-N-(phenylmethyl)benzamide

C21H19N3O2 (345.1477)


   

2-(4-Tert-butylphenyl)-3-oxo-3-[2-(trifluoromethyl)phenyl]propanenitrile

2-(4-Tert-butylphenyl)-3-oxo-3-[2-(trifluoromethyl)phenyl]propanenitrile

C20H18F3NO (345.134)


   

2,3,7-Triphenyl-1H-indole

2,3,7-Triphenyl-1H-indole

C26H19N (345.1517)


   

4-(2-(1H-imidazol-4-yl)ethylamino)-2-(phenylamino)pyrazolo[1,5-a][1,3,5]triazine-8-carbonitrile

4-(2-(1H-imidazol-4-yl)ethylamino)-2-(phenylamino)pyrazolo[1,5-a][1,3,5]triazine-8-carbonitrile

C17H15N9 (345.145)


   

gibberellic acid A6

gibberellic acid A6

C19H21O6- (345.1338)


   

(1R,2R,5S,8S,9S,10R,11R,12S)-5,12-dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadec-13-ene-9-carboxylate

(1R,2R,5S,8S,9S,10R,11R,12S)-5,12-dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadec-13-ene-9-carboxylate

C19H21O6- (345.1338)


   

gibberellin A3(1-)

gibberellin A3(1-)

C19H21O6- (345.1338)


A gibberellin carboxylic acid anion obtained by deprotonation of the carboxy group of gibberellin A3. D006133 - Growth Substances > D010937 - Plant Growth Regulators > D005875 - Gibberellins

   

(5E)-5-[(1-cyclohexyl-2,5-dimethylpyrrol-3-yl)methylidene]-1-methyl-2-sulfanylidene-1,3-diazinane-4,6-dione

(5E)-5-[(1-cyclohexyl-2,5-dimethylpyrrol-3-yl)methylidene]-1-methyl-2-sulfanylidene-1,3-diazinane-4,6-dione

C18H23N3O2S (345.1511)


   

N-(2-furanylmethyl)-6-(3-methoxyphenyl)-N-methyl-4-quinazolinamine

N-(2-furanylmethyl)-6-(3-methoxyphenyl)-N-methyl-4-quinazolinamine

C21H19N3O2 (345.1477)


   

1-[4-(3-Propan-2-yloxyphenyl)-2-thiazolyl]-4-piperidinecarboxamide

1-[4-(3-Propan-2-yloxyphenyl)-2-thiazolyl]-4-piperidinecarboxamide

C18H23N3O2S (345.1511)


   

1-[4-(4-Propan-2-yloxyphenyl)-2-thiazolyl]-4-piperidinecarboxamide

1-[4-(4-Propan-2-yloxyphenyl)-2-thiazolyl]-4-piperidinecarboxamide

C18H23N3O2S (345.1511)


   

3-Butyl-10-phenylpyrimido[4,5-b]quinoline-2,4-dione

3-Butyl-10-phenylpyrimido[4,5-b]quinoline-2,4-dione

C21H19N3O2 (345.1477)


   

4-[[2-(4-Ethyl-1-piperazinyl)-2-oxoethyl]thio]-1-methyl-2-quinolinone

4-[[2-(4-Ethyl-1-piperazinyl)-2-oxoethyl]thio]-1-methyl-2-quinolinone

C18H23N3O2S (345.1511)


   

N-(2-oxolanylmethyl)-2-(1-piperidinyl)-1,3-benzothiazole-6-carboxamide

N-(2-oxolanylmethyl)-2-(1-piperidinyl)-1,3-benzothiazole-6-carboxamide

C18H23N3O2S (345.1511)


   

Methyl 2-[1-(2-methyl-1H-indol-3-yl)-2-naphthyl]hydrazinecarboxylate

Methyl 2-[1-(2-methyl-1H-indol-3-yl)-2-naphthyl]hydrazinecarboxylate

C21H19N3O2 (345.1477)


   

2-(3-Pyridyl)-3-(4-toluenesulfonamido)propylazetidine

2-(3-Pyridyl)-3-(4-toluenesulfonamido)propylazetidine

C18H23N3O2S (345.1511)


   

4-Cyano-5-methyl-6-phenyl-2-(para-tolyl)perhydropyrrolo(3,4-C)pyrrole-1,3-dione (3A,4-trans-6,6A-cis)

4-Cyano-5-methyl-6-phenyl-2-(para-tolyl)perhydropyrrolo(3,4-C)pyrrole-1,3-dione (3A,4-trans-6,6A-cis)

C21H19N3O2 (345.1477)


   

4-Cyano-5-methyl-6-phenyl-2-(para-tolyl)perhydropyrrolo(3,4-C)pyrrole-1,3-dione (3A,4-trans-6,6A-trans)

4-Cyano-5-methyl-6-phenyl-2-(para-tolyl)perhydropyrrolo(3,4-C)pyrrole-1,3-dione (3A,4-trans-6,6A-trans)

C21H19N3O2 (345.1477)


   

4-Cyano-5-methyl-6-phenyl-2-(para-tolyl)perhydropyrrolo(3,4-C)pyrrole-1,3-dione (3A,4-cis-6,6A-cis)

4-Cyano-5-methyl-6-phenyl-2-(para-tolyl)perhydropyrrolo(3,4-C)pyrrole-1,3-dione (3A,4-cis-6,6A-cis)

C21H19N3O2 (345.1477)


   

4-Cyano-5-methyl-6-phenyl-2-(para-tolyl)perhydropyrrolo(3,4-C)pyrrole-1,3-dione (3A,4-cis-6,6A-trans)

4-Cyano-5-methyl-6-phenyl-2-(para-tolyl)perhydropyrrolo(3,4-C)pyrrole-1,3-dione (3A,4-cis-6,6A-trans)

C21H19N3O2 (345.1477)


   

1-Methyl-3,4-bis(methoxycarbonyl)-2-trimethylsilyl-5-phenylpyrrole

1-Methyl-3,4-bis(methoxycarbonyl)-2-trimethylsilyl-5-phenylpyrrole

C18H23NO4Si (345.1396)


   

SCH 58261

2-(Furan-2-yl)-7-phenethyl-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine

C18H15N7O (345.1338)


D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D020011 - Protective Agents SCH 58261 is a potent, selective and competitive antagonist of adenosine A2A receptor with an IC50 of 15 nM, and displays 323-, 53- and 100-fold more selective for A2A receptor than A1, A2B, and A3 receptors, respectively[1][2][3].

   

N-Methylnuciferine

N-Methylnuciferine

C20H24ClNO2 (345.1495)


N-Methylnuciferine, an alkaloid from Lotus Plumule, ameliorate lipopolysaccharide-induced depression-like behavior[1].

   

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[5-(hydroxymethyl)-4-(methoxymethyl)-2-methylpyridin-3-yl]oxy}oxane-3,4,5-triol

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[5-(hydroxymethyl)-4-(methoxymethyl)-2-methylpyridin-3-yl]oxy}oxane-3,4,5-triol

C15H23NO8 (345.1424)


   

16-methoxycarbonylnaufoline

NA

C21H19N3O2 (345.1477)


{"Ingredient_id": "HBIN001926","Ingredient_name": "16-methoxycarbonylnaufoline","Alias": "NA","Ingredient_formula": "C21H19N3O2","Ingredient_Smile": "COC(=O)C1=CN=CC2=C1C=CC3C4=C(CCN3C2)C5=CC=CC=C5N4","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13869","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

19-o-methylangustoline

NA

C21H19N3O2 (345.1477)


{"Ingredient_id": "HBIN002206","Ingredient_name": "19-o-methylangustoline","Alias": "NA","Ingredient_formula": "C21H19N3O2","Ingredient_Smile": "CC(C1=C2C=C3C4=C(CCN3C(=O)C2=CN=C1)C5=CC=CC=C5N4)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14132","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-2h-pyrrolo[1,2-a]pyrazine-1,4-dione

3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-2h-pyrrolo[1,2-a]pyrazine-1,4-dione

C21H19N3O2 (345.1477)


   

methyl 4-(2-chloroethyl)-2-[cyclohex-2-en-1-yl(hydroxy)methyl]-3,5-dihydroxy-3-methyl-4h-pyrrole-2-carboxylate

methyl 4-(2-chloroethyl)-2-[cyclohex-2-en-1-yl(hydroxy)methyl]-3,5-dihydroxy-3-methyl-4h-pyrrole-2-carboxylate

C16H24ClNO5 (345.1343)


   

19-(1-methoxyethyl)-3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

19-(1-methoxyethyl)-3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

C21H19N3O2 (345.1477)


   

19-[(1r)-1-methoxyethyl]-3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

19-[(1r)-1-methoxyethyl]-3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

C21H19N3O2 (345.1477)


   

2-(hydroxymethyl)-6-{[5-(hydroxymethyl)-4-(methoxymethyl)-2-methylpyridin-3-yl]oxy}oxane-3,4,5-triol

2-(hydroxymethyl)-6-{[5-(hydroxymethyl)-4-(methoxymethyl)-2-methylpyridin-3-yl]oxy}oxane-3,4,5-triol

C15H23NO8 (345.1424)


   

methyl (2r,3s,4r)-4-(2-chloroethyl)-2-[(s)-(1s)-cyclohex-2-en-1-yl(hydroxy)methyl]-3,5-dihydroxy-3-methyl-4h-pyrrole-2-carboxylate

methyl (2r,3s,4r)-4-(2-chloroethyl)-2-[(s)-(1s)-cyclohex-2-en-1-yl(hydroxy)methyl]-3,5-dihydroxy-3-methyl-4h-pyrrole-2-carboxylate

C16H24ClNO5 (345.1343)


   

(2s)-5-carbamimidamido-2-[2-(1h-indol-3-yl)-2-oxoacetamido]pentanoic acid

(2s)-5-carbamimidamido-2-[2-(1h-indol-3-yl)-2-oxoacetamido]pentanoic acid

C16H19N5O4 (345.1437)


   

(3z)-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-2h-pyrrolo[1,2-a]pyrazine-1,4-dione

(3z)-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-2h-pyrrolo[1,2-a]pyrazine-1,4-dione

C21H19N3O2 (345.1477)


   

5-carbamimidamido-2-[2-(1h-indol-3-yl)-2-oxoacetamido]pentanoic acid

5-carbamimidamido-2-[2-(1h-indol-3-yl)-2-oxoacetamido]pentanoic acid

C16H19N5O4 (345.1437)